[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 73, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2024, "totalPay": 748600, "exercisedValue": 0, "unexercisedValue": 809000}, {"maxAge": 1, "name": "Mr. Mark Patrick Guerin C.M.A., CPA, CFM", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen M.B.A.", "title": "Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.66, "open": 3.61, "dayLow": 3.49, "dayHigh": 3.72, "regularMarketPreviousClose": 3.66, "regularMarketOpen": 3.61, "regularMarketDayLow": 3.49, "regularMarketDayHigh": 3.72, "payoutRatio": 0.0, "beta": 1.486, "forwardPE": -3.1578946, "volume": 286933, "regularMarketVolume": 286933, "averageVolume": 1915637, "averageVolume10days": 703030, "averageDailyVolume10Day": 703030, "bid": 3.6, "ask": 3.61, "bidSize": 1000, "askSize": 400, "marketCap": 95410392, "fiftyTwoWeekLow": 1.11, "fiftyTwoWeekHigh": 5.6, "allTimeHigh": 132.0, "allTimeLow": 1.11, "fiftyDayAverage": 3.1548, "twoHundredDayAverage": 2.42745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 80124000, "profitMargins": 0.0, "floatShares": 22408193, "sharesOutstanding": 26502889, "sharesShort": 2858006, "sharesShortPriorMonth": 1314516, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1078, "heldPercentInsiders": 0.1545, "heldPercentInstitutions": 0.11512, "shortRatio": 0.71, "shortPercentOfFloat": 0.1205, "impliedSharesOutstanding": 26502889, "bookValue": 0.652, "priceToBook": 5.521472, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -24884444, "trailingEps": -1.43, "forwardEps": -1.14, "52WeekChange": -0.27952754, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 3.6, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 13.75, "targetMedianPrice": 13.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 15286399, "totalCashPerShare": 0.577, "totalDebt": 0, "quickRatio": 4.094, "currentRatio": 4.604, "returnOnAssets": -1.05878, "returnOnEquity": -2.46139, "freeCashflow": -15614118, "operatingCashflow": -24978014, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "exchange": "NYQ", "messageBoardId": "finmb_622711087", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.63935, "regularMarketPrice": 3.6, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580308200000, "postMarketChangePercent": 0.0, "postMarketPrice": 3.6, "postMarketChange": 0.0, "regularMarketChange": -0.0600002, "regularMarketDayRange": "3.49 - 3.72", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 1915637, "fiftyTwoWeekLowChange": 2.4899998, "fiftyTwoWeekLowChangePercent": 2.243243, "fiftyTwoWeekRange": "1.11 - 5.6", "fiftyTwoWeekHighChange": -2.0, "fiftyTwoWeekHighChangePercent": -0.35714287, "fiftyTwoWeekChangePercent": -27.952755, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.43, "epsForward": -1.14, "epsCurrentYear": -1.29, "priceEpsCurrentYear": -2.7906976, "fiftyDayAverageChange": 0.44519997, "fiftyDayAverageChangePercent": 0.14111829, "twoHundredDayAverageChange": 1.17255, "twoHundredDayAverageChangePercent": 0.48303774, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1766791134, "regularMarketTime": 1766782802, "displayName": "Annovis Bio", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]